Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
株式のランク #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
株価
$0.94
最終同期: 2025-02-28
時価総額
$2.73M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Fresh Tracks Therapeutics, Inc. (FRTX)

カテゴリー

Fresh Tracks Therapeutics, Inc.(FRTX)の営業利益率
August 2026 時点の営業利益率 TTM: -79.44%
Fresh Tracks Therapeutics, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -79.44% です。2022 年末時点では -310.15% でした。
Fresh Tracks Therapeutics, Inc. の営業利益率の履歴(2000 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -79.44% 0.00%
2023 -79.44% -74.39%
2022 -310.15% -96.89%
2021 -9,961.39% 765.26%
2020 -1,151.26% 272.50%
2019 -309.06% -74.48%
2018 -1,211.22% 1,150.36%
2017 -96.87% 53.40%
2016 -63.15% 40.68%
2015 -44.89% -58.91%
2014 -109.26% -73.10%
2013 -406.22% 203.69%
2012 -133.76% 413.28%
2011 -26.06% -92.73%
2010 -358.34% 59.02%
2009 -225.34% -51.99%
2008 -469.37% -35.74%
2007 -730.44% 307.57%
2006 -179.22% -16.13%
2005 -213.70% 23.63%
2004 -172.86% -46.50%
2003 -323.12% -28.41%
2002 -451.36% 197.75%
2001 -151.59% -28.52%
2000 -212.06% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
38.59% -100.49%
US
28.81% -100.36%
NL
0.00% -
CH
0.00% -
KR
31.23% -100.39%
BE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。